首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Use of Pinus sylvestris L. (Pinaceae) Origanum vulgare L. (Lamiaceae) and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptibleot-susceptible Cryptococcus neoformans strains
【2h】

Use of Pinus sylvestris L. (Pinaceae) Origanum vulgare L. (Lamiaceae) and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptibleot-susceptible Cryptococcus neoformans strains

机译:樟子松(Pinaceae)牛至(Origanum vulgare L.(Lamiaceae)和百里香(Thymus vulgaris L.(Lamiaceae))精油及其主要成分的使用可增强伊曲康唑对易受唑敏感性/不易感的新隐球菌菌株的活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCryptococcal infections, besides being a problem for immunocompromised patients, are occasionally being a problem for immunocompetent patients. In addition, the lower susceptibility of this yeast to azoles is a growing problem in health care. To date, there are very few molecules with any activity towards Cryptococcus neoformans, leading to heightened interest in finding new alternatives or adjuvants to conventional drugs for the treatment of mycosis caused by this yeast. Since the essential oils (EOs) are considered as a potential rich source of bioactive antimicrobial compounds, we evaluated the antifungal activity of Origanum vulgare (oregano), Pinus sylvestris (pine), and Thymus vulgaris (thyme red) EOs, and their components (α-pinene, carvacrol, thymol) compared with fluconazole, itraconazole, and voriconazole, against C.neoformans clinical strains. Then, we investigated the effect of EOs and components in combination with itraconazole.
机译:背景技术隐球菌感染除了是免疫功能低下患者的问题外,有时也是免疫能力强的患者的问题。另外,该酵母对唑类的较低敏感性在卫生保健中是一个日益严重的问题。迄今为止,几乎没有任何分子对新隐球菌具有活性,从而引起了人们对于寻找新的替代品或佐剂来治疗这种酵母菌引起的真菌病的兴趣。由于香精油(EOs)被认为是生物活性抗微生物化合物的潜在丰富来源,因此我们评估了牛至(oregano),樟子松(pine)和百里香(百里香红)EOs及其组分的抗真菌活性(与氟康唑,伊曲康唑和伏立康唑相比,α-pine烯,香芹酚,百里香酚对付新孢子虫临床菌株。然后,我们研究了伊曲康唑与EOs和组分的作用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号